Elicio Therapeutics Inc. (NASDAQ: ELTX) Stock Information | RedChip

Elicio Therapeutics Inc. (NASDAQ: ELTX)


$5.0000
-0.0300 ( -0.79% ) 3.7K

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Market Data


Open


$5.0000

Previous close


$5.0300

Volume


3.7K

Market cap


$54.10M

Day range


$5.0400 - $5.1200

52 week range


$2.9600 - $11.4500

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Dec 18, 2024
8-k 8K-related 52 Dec 12, 2024
8-k 8K-related 15 Dec 03, 2024
4 Insider transactions 1 Nov 29, 2024
4 Insider transactions 1 Nov 25, 2024
4 Insider transactions 1 Nov 25, 2024
4 Insider transactions 1 Nov 25, 2024
4 Insider transactions 1 Nov 25, 2024
4 Insider transactions 1 Nov 25, 2024
4 Insider transactions 1 Nov 25, 2024

Latest News